E1	Condition:T1 Name:T2
E3	Condition:T3 Name:T4 Severity:T40
E5	Condition:T5 Name:T6
E10	Eq-Comparison:T13 Operator:T11 Value:T12 Unit:T45 Per:T46
E12	Eq-Comparison:T16 Temporal-Period:T17
E2	Condition:T18 Name:T19
E4	Modifier:T20 Modifies:T19
E6	Condition:T21 Name:T22 Stage:E8
E8	Eq-Comparison:T23 Unit:T24 Value:T25 Value2:T26 Value3:T27
E11	Condition:T14 Name:T15 Temporality:E12
E13	Modifier:T28 Modifies:T15
E14	Condition:T29 Name:T30 Temporality:E15
E15	Eq-Comparison:T31 Temporal-Period:T32
E16	Eq-Comparison:T33 Temporal-Period:T34
E17	Or:T35 Arg:E16 Arg2:E15
E9	Modifier:T9 Modifies:T4
E18	Modifier:T10 Modifies:T4
E19	Modifier:T36 Modifies:T4
E20	Modifier:T37 Modifies:T4
E21	Modifier:T38 Modifies:T4
E22	Or:T39 Arg:E18 Arg2:E9
E23	Condition:T41 Name:T42
E24	Observation:T43 Name:T44 Eq-Comparison:E10
E25	Study:T47
E26	Temporal-Connection:T48 Arg:E24 Arg2:E25
E27	Condition:T49 Name:T50 Polarity:T51
E28	Condition:T52 Name:T53
E7	Modifier:T7 Modifies:T53
E29	Modifier:T8 Modifies:T53
E30	Or:T54 Arg:E7 Arg2:E29
E31	Procedure:T55 Name:T56
E32	Contraindication:T57 Contraindicates:E31
E33	Condition:T58 Severity:T60
E34	Modifier:T59 Modifies:E33
E35	Or:T61 Arg:T60 Arg2:E34
E36	Study:T62
E37	Risk:T63 Stability:T64
E38	Assertion:T65 Asserted:T64
E39	Drug:T66 Name:T67
E40	Or:T68 Arg:E36 Arg2:E39
E41	Study:T69
E42	Other:T70 Is-Other:E41
E43	Encounter:T71
E44	Negation:T72 Negates:E43
E45	Assertion:T73 Asserted:E44
T1	Condition 437 419	Neurodegenerative disorders
T2	Condition-Name 437 419	Neurodegenerative disorders
T3	Condition 396 380	disease
T4	Condition-Name 396 380	disease
T5	Condition 482 464	Immunosuppression
T6	Condition-Name 482 464	Immunosuppression
T11	Eq-Operator 502 483	<
T12	Eq-Value 511 488	3,000
T13	Eq-Comparison 522 497	<3,000 cells/ml
T16	Eq-Comparison 227 216	Prior
T17	Eq-Temporal-Period 227 216	Prior
T18	Condition 143 138	SCI
T19	Condition-Name 143 138	SCI
T20	Modifier 139 134	non-penetrating traumatic
T21	Condition 170 165	Asia Impairment Scale
T22	Condition-Name 170 165	Asia Impairment Scale
T23	Eq-Comparison 192 185	grade of A, B, or C
T24	Eq-Unit 176 171	grade
T25	Eq-Value 181 176	A
T26	Eq-Value 185 179	B
T27	Eq-Value 192 185	C
T14	Condition 264 251	injury
T15	Condition-Name 264 251	injury
T28	Modifier 257 244	Brain
T29	Condition 302 289	infection
T30	Condition-Name 302 289	infection
T31	Eq-Comparison 292 279	ongoing
T32	Eq-Temporal-Period 292 279	ongoing
T33	Eq-Comparison 281 268	Recent
T34	Eq-Temporal-Period 281 268	Recent
T35	Or 284 271	or
T9	Modifier 388 372	endocrine
T10	Modifier 375 359	hepatic
T36	Modifier 365 350	renal
T37	Modifier 357 343	lung
T38	Modifier 350 337	cardiovascular
T39	Or 378 362	or
T40	Severity 335 322	significant
T41	Condition 454 436	Cancer
T42	Condition-Name 454 436	Cancer
T43	Observation 500 482	WBC
T44	Observation-Name 500 482	WBC
T45	Eq-Unit 517 494	cells
T46	Eq-Unit 522 497	ml
T47	Study 534 509	baseline
T48	Temporal-Connection 525 500	at
T49	Condition 561 534	HIV
T50	Condition-Name 561 534	HIV
T51	Polarity 563 535	+
T52	Condition 602 573	dependency
T53	Condition-Name 602 573	dependency
T7	Modifier 583 554	Chemical
T8	Modifier 591 562	ETOH
T54	Or 586 557	or
T55	Procedure 642 611	MRI
T56	Procedure-Name 642 611	MRI
T57	Contraindication 635 604	contraindication
T58	Condition 697 664	medical conditions
T59	Modifier 678 645	chronic
T60	Severity 667 634	acute
T61	Or 670 637	or
T62	Study 786 751	study
T63	Risk 764 729	risks
T64	Stability 754 719	increase
T65	Assertion 745 710	may
T66	Drug 814 777	HB-adMSC
T67	Drug-Name 814 777	HB-adMSC
T68	Or 803 768	or
T69	Study 891 852	studies
T70	Other 859 820	other
T71	Encounter 945 902	follow-up visits
T72	Negation 912 871	Unwillingness
T73	Assertion 912 871	Unwillingness
A1	Eq-Operator-Value T11 LT
A3	Eq-Temporal-Period-Value T17 past
A2	Eq-Temporal-Period-Value T32 present
A4	Eq-Temporal-Period-Value T34 recent
A5	Severity-Value T40 severe
A6	Observation-Type-Value T44 lab
A7	Temporal-Connection-Type-Value E26 during
A8	Polarity-Value T51 positive
A9	Severity-Value T60 severe
A10	Stability-Value T64 change
A11	Assertion-Type-Value E38 hypothetical
A12	Assertion-Type-Value E45 hypothetical
R1	Equivalent-To Arg1:E24 Arg2:E5
R2	Caused-By Arg1:E36 Arg2:E37
R3	Caused-By Arg1:T64 Arg2:E33